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Abstract
Quantifying the differential expression of genes in various human
organs, tissues, and cell types is vital to understand human physio-
logy and disease. Recently, several large-scale transcriptomics
studies have analyzed the expression of protein-coding genes
across tissues. These datasets provide a framework for defining
the molecular constituents of the human body as well as for
generating comprehensive lists of proteins expressed across tissues
or in a tissue-restricted manner. Here, we review publicly available
human transcriptome resources and discuss body-wide data from
independent genome-wide transcriptome analyses of different
tissues. Gene expression measurements from these independent
datasets, generated using samples from fresh frozen surgical speci-
mens and postmortem tissues, are consistent. Overall, the different
genome-wide analyses support a distribution in which many
proteins are found in all tissues and relatively few in a tissue-
restricted manner. Moreover, we discuss the applications of
publicly available omics data for building genome-scale metabolic
models, used for analyzing cell and tissue functions both in physio-
logical and in disease contexts.
Keywords genome-scale metabolic models; proteomics; transcriptomics
DOI 10.15252/msb.20155865 | Received 28 September 2015 | Revised 15
February 2016 | Accepted 17 February 2016
Mol Syst Biol. (2016) 12: 862
Introduction
The global classification of the human proteome with regard to its
spatiotemporal expression patterns and its functions represents
one of the major challenges for studying human biology and
disease (Lamond et al, 2012). Recently, genomic, transcriptomic,
and proteomic technologies have been employed to analyze the
human proteome on a genome-wide level. Genome annotation
efforts, such as Ensembl (Cunningham et al, 2015) and Gencode
consortium (Harrow et al, 2012) in the Encode project (Nilsson
et al, 2015), have identified approximately 20,000 genes coding
for proteins, and the UniProt consortium (UniProt, 2015) has
manually annotated the majority of these genes. On the transcript
level, expression levels of human genes have been monitored to
study the effects of diseases, treatments, and developmental stages
using microarray-based gene expression profiling (Brawand et al,
2011; Petryszak et al, 2015). Recently, several efforts have been
published with the quantitative analysis of RNA levels based on
next-generation sequencing in samples representing most of the
major organs and tissues in the human body (Fig 1), including
the Fantom consortium (Yu et al, 2015), the Human Protein Atlas
(HPA) consortium (Uhlen et al, 2015), and the genome-based
tissue expression (GTEx) consortium (Keen & Moore, 2015). On
the protein level, several large-scale studies based on mass spec-
trometry analysis have also been published (Kim et al, 2014;
Wilhelm et al, 2014), and these studies have been complemented
with antibody-based protein profiling using tissue microarrays
containing samples representing most major tissues and organs in
the human body (Fagerberg et al, 2014; Uhlen et al, 2015). Most
of the quantitative data on the expression of protein-coding genes
are based on recent transcriptomics studies based on RNA-seq.
Here, we review some of the publicly available human transcrip-
tome resources and discuss tissue data from independent research
groups.
An interesting aspect of the integration of omics technologies is
the sampling that depends on the sensitivity and the resolution of
each technology. Consequently, the analysis of tissue samples is
normally performed on a mixture of cell types using transcriptomics
and mass spectrometry-based proteomics, whereas in situ
hybridization techniques, successfully applied for mapping the
distribution of transcripts in the brain (Hawrylycz et al, 2012), and
more qualitative approaches involving antibody-based profiling
allow analyzing single cells in their natural environment to reveal
the differences in protein expression levels between neighboring
cells. Thus, antibody-based protein profiling complements quantita-
tive transcriptomics and proteomics, based on a mixture of cell
types, to reach single-cell resolution in the analysis of gene expres-
sion in complex tissues. Recently, single-cell technologies have been
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developed for transcriptomics (Tang et al, 2009), but no global
analysis across many tissues has yet been published using such
methodology. In the near future, the possibility to move to single-
cell analyses of tissues for transcriptomics and proteomics will allow
analyzing cell-to-cell variability, which is particular interesting, that
is, in the context of cancer. Moreover, the development of more
quantitative assays for immunohistochemistry using fluorescent
probes will be valuable for providing quantitative data for
whole-cell modeling (Stadler et al, 2013).
The correlation between mRNA levels and the corresponding
protein levels is an important issue for the comparability of the dif-
ferent omics-based technologies, and the presence or absence of
such correlation on an individual gene/protein level has been
debated in the literature for many years (Anderson & Seilhamer,
1997; Tian et al, 2004; Gry et al, 2009; Maier et al, 2009, 2011;
Lundberg et al, 2010; Schwanhausser et al, 2011). However, a
comparison of steady-state levels of mRNA and proteins in human
cell lines using RNA-seq and quantitative triple-SILAC analysis
showed good genome-wide correlations when the mRNA and
protein levels of an individual gene were compared in three sepa-
rate cell lines (Lundberg et al, 2010). These observations were
supported by Kuster and coworkers (Wilhelm et al, 2014) compar-
ing mass spectrometry data from different tissues with RNA-seq
data obtained from the HPA consortium (Uhlen et al, 2015). Again,
the steady-state levels for individual genes correlated across several
tissues. Overall, these studies suggest that the amount of a given
protein in a cell or tissue is, in general, reflected by the correspond-
ing mRNA level, although this gene-/protein-specific ratio may vary
greatly between different gene products depending on various
factors, mainly translational rates and protein half-lives (Eden et al,
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Figure 1. Global transcriptomics analysis of human tissues and organs.
Overview of the tissues and organs analyzed using RNA-seq by the Human Protein Atlas consortium (HPA, green), tissues studied with cap analysis gene expression (CAGE)
within the FANTOM consortium (purple), and tissues analyzed using RNA-seq by the genome-based tissue expression consortium (GTEx, orange). Altogether, 22 tissues
and organs were studied with both the HPA and FANTOM datasets, while 21 tissues overlapped between the HPA and GTEx datasets.
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2011), and the transcript level for a given gene might therefore be
used to predict the corresponding protein level. This hypothesis
needs to be confirmed by more in-depth studies using quantitative
measurements at both the RNA and protein levels. However, it
suggests that next-generation sequencing of the transcriptome is a
powerful tool for indirect measurements of protein expression
levels, thus forming an attractive link between the field of genomics
and proteomics.
Analyses of the human transcriptome by
different methods
Several genome-wide transcriptome profiling methods have been
used for identifying and quantifying global gene expression
patterns, each allowing for a quantitative analysis of RNA tran-
scripts. Whole-body maps based on microarray analyses have been
launched, such as BioGPS (Wu et al, 2009), and these have recently
been followed by several tissue-based data portals based on RNA-
seq. Some of these publicly available repositories for transcrip-
tomics data are summarized in Table 1 with a focus on datasets
from RNA-seq experiments. The resources include repositories for
external data, such as Expression Atlas from the European Bioinfor-
matics Institute (EBI) and Gene Expression Omnibus from the
National Center for Biotechnology Information (NCBI), as well as
repositories with internally generated transcriptome data, such as
the GTEx, the Human Protein Atlas, and the Allen Brain Atlas. In a
recent study (Danielsson et al, 2015), the concordance of RNA-seq
data from four large-scale efforts was compared based on gene
expression measurements for ostensibly similar samples (specifi-
cally, human brain, heart, and kidney samples). The authors
concluded that human tissue RNA-seq expression measurements
appear quite consistent, considering that samples cluster by tissue
rather than laboratory of origin given simple preprocessing
transformations.
An alternative approach to RNA-seq, named cap analysis gene
expression (CAGE), has been described by the Fantom consortia
(Yu et al, 2015) and allows for quantitative measurements of tran-
scripts based on sequencing the 50-end of capped mRNA molecules.
The correlation between RNA-seq and CAGE for transcriptome
analysis was recently investigated (Yu et al, 2015), and the tran-
scriptome of 22 tissues was analyzed using both methods (Fig 1)
based on 79 RNA-seq (HPA) and 27 CAGE (FANTOM) samples.
Tissue-to-tissue comparisons showed a high genome-wide correla-
tion between the two datasets (Yu et al, 2015). Interestingly,
discrepancies between the two datasets can largely be explained by
gene model annotation issues or technical artifacts inherent in the
respective methodologies. As an example, the HPA data excluded
mRNA without poly-adenylation tails and it is therefore not surpris-
ing that many histone genes were lacking in the RNA-seq data, but
are present in the CAGE data. Conversely, CAGE peaks mapping
more than 500 base pairs from the transcriptional start site are lack-
ing in the CAGE dataset, as well as CAGE peaks mapping to two or
more locations on the genome, which are removed from the dataset.
Thus, the two methods are complementary and it would be attrac-
tive to integrate data obtained by these two approaches to refine
gene models and to improve the interpretation of gene expression
values.
Classification of all human protein-coding genes based on
tissue profiling
The different omics-based analyses of the human proteome have
allowed the classification of protein-coding genes with regard to
tissue-restricted expression. In the analysis performed by the HPA
consortium (Fagerberg et al, 2014; Uhlen et al, 2015), a cutoff of 1
FPKM (Hebenstreit et al, 2011) was used to indicate the presence or
absence of transcripts for a particular gene in a tissue. Based on this
definition, all human protein-coding genes were classified into (i)
genes with an elevated expression in one or several tissues, (ii)
genes expressed in all analyzed tissues, (iii) genes with mixed
expression found in several, but not all tissues, and (iv) genes not
detected in any tissues. The elevated genes were further stratified
into “tissue enriched”, “group enriched”, or “tissue enhanced”. The
term “tissue specific” was avoided as it depends on the definition of
cutoff values, and only few genes, including well-known proteins
such as insulin, PSA, and troponin, were found to be exclusively
expressed in a single tissue type (Uhlen et al, 2015). A classification
of all protein-coding genes is shown in Table 2 (cutoff of 0.5
FPKM).
The classification of the human protein-coding transcriptome
showed that almost half of the genes were detected in all tissues
(45%), while 13% showed a mixed expression (Fig 2A). Approxi-
mately one-third of the genes showed a tissue elevated expression
with 13% of the genes enriched in one of the analyzed tissues. Only
5% of the genes were not detected in any of the analyzed tissues. A
further analysis of the number of genes with a tissue elevated
expression (Fig 2B) showed that the testis has by far the highest
number of tissue-enriched genes followed by the brain (cerebral
cortex) and liver.
The recently published RNA-Seq data generated by the GTEx
consortium (Bahcall, 2015; GTEx Consortium, 2015; Gibson, 2015)
allow for an independent tissue-based classification of the human
proteome. The GTEx dataset includes more than 1,600 postmortem
samples from mostly overlapping, but in some cases unique, tissues
compared to the HPA consortium (Fig 1). For example, the GTEx
dataset includes more tissue samples from the brain, blood, and
nerves, which are not included in the HPA dataset. As illustrated in
Fig 2C, the overall tissue-based classification based on the GTEx
dataset and an identical cutoff of 0.5 FPKM is similar to that of the
HPA with 45% of the genes expressed in all tissues, 14% showing a
mixed expression, 12% being tissue-enriched expression, and 5% of
the genes not detected in any of the analyzed tissues. With respect
to tissue-elevated genes (Fig 2B and D) the testis is again observed
to contain the largest number of tissue-enriched genes, followed by
the brain (cerebellum, cortex, and pituitary), skin, and liver. The
values for the HPA and the GTEx datasets can be found in
Table EV1.
Tissue-enriched genes vs. ubiquitously expressed genes
Tissue-enriched genes identified by the analysis of the HPA data
(Uhlen et al, 2015) based on the definitions shown in Table 2 can
be found for all tissues in the interactive HPA database (www.
proteinatlas.org/humanproteome/tissue+specific). A functional
Gene Ontology analysis of the tissue-enriched genes in the HPA
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dataset has been performed and the results are consistent with
the function of each tissue (Uhlen et al, 2015). As an example,
genes elevated in liver encode secreted plasma and bile proteins,
detoxification proteins, and proteins associated with metabolic
processes and glycogen storage (Kampf et al, 2014), whereas
genes elevated in adipose tissue encode proteins involved in
lipid metabolic processes (Mardinoglu et al, 2014b) and genes
elevated in skin encode proteins associated with functions
related to the barrier function (squamous cell differentiation and
cornification), skin pigmentation, and hair development (Edqvist
et al, 2015). In order to further validate these lists, we have
compared the overlap of tissue-enriched genes identified using
the independent HPA and GTEx datasets. The number of tissue-
enriched genes in the different tissues and the overlap between
the two datasets are shown in Figs 2E and 3A, and Table EV2.
Overall, it is reassuring that there is a significant overlap in the
tissue classification of the genes based on the two independent
datasets. The fact that similar results are obtained when using
fresh frozen tissue (HPA) and postmortem tissue (GTEx)
suggests negligible effects of the sampling procedures used by
the GTEx consortium on RNA degradation. In the comparison,
note that in the HPA dataset, the brain contains only one tissue
(cerebral cortex), while the corresponding GTEx dataset is based
on three different tissues (cerebellum, cortex, and pituitary). The
large discrepancy for skin can be explained by the fact that the
sampling of skin in the HPA was based on shave biopsies
including mainly epidermis (Uhlen et al, 2015), while the GTEx
consortium also included the underlying dermis, most likely
containing skin adnexal structures such as hair follicles and
sweat glands.
Table 1. Data resources for RNA expression data with relevance for human protein-encoding genes.
Resource Affiliation Description Link (URL) References
Human Protein
Atlas
Science for Life Lab
(Sweden)
Tissue-based RNA data based on surgically
removed tissues (RNA-Seq)
http://www.proteinatlas.org/ (Uhlen et al, 2015)
GTEx Broad Institute (USA) Tissue-based RNA data based on postmortem
samples (RNA-Seq)
http://gtexportal.org/home/ (Keen & Moore, 2015)
FANTOM Riken Institute (Japan) Tissue-based RNA data based on CAGE http://fantom.gsc.riken.jp/ (Yu et al, 2015)
RNA-Seq Atlas J. Gutenberg University
(Germany)
A reference database for gene expression
profiling in normal tissue by next-generation
sequencing
http://medicalgenomics.org/
rna_seq_atlas
(Krupp et al, 2012)
Allen Brain Atlas Allen Institute (USA) An anatomically comprehensive atlas of the
adult human brain transcriptome
http://human.brain-map.org/ (Hawrylycz et al, 2012)
Evolution of gene
expression
University of Lausanne
(Switzerland)
The evolution of gene expression levels in
mammalian organs
http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE30352
(Brawand et al, 2011)
AltIso MIT (USA) Alternative isoform regulation in human
tissue transcriptomes.
http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE12946
(Wang et al, 2008)
Expression Atlas EBI (UK) Repository for RNA expression data
(both microarray and RNA-Seq)
https://www.ebi.ac.uk/gxa (Petryszak et al, 2015)
ArrayExpress EBI (UK) International functional genomics public
data repositories
http://www.ebi.ac.uk/arrayexpress/ (Rustici et al, 2013)
Illumina Body
Map
Illumina (USA) RNA-Seq of 16 human individual tissues http://www.ebi.ac.uk/arrayexpress/
experiments/E-MTAB-513/
(Rustici et al, 2013)
Gene Expression
Omnibus
NCBI (USA) Repository for RNA expression data
(both microarray and RNA-Seq)
http://www.ncbi.nlm.nih.gov/geo/ (Barrett et al, 2013)
Table 2. Classification of all human protein-coding genes based on transcript expression levels in tissues and organs. The columns HPA and GTEx
indicate the number of genes identified in the different categories using the datasets (Keen & Moore, 2015; Uhlen et al, 2015) from these two
consortia.
Category Definition HPA GTEx
Tissue enriched At least fivefold higher mRNA levels (FPKM) in a particular tissue as compared to all other tissues 2,359 2,289
Group enriched At least fivefold higher mRNA levels in a group of tissues (2–7) 1,208 1,307
Enhanced At least fivefold higher mRNA levels in a particular tissue as compared to the average levels in all tissues 3,227 3,077
Expressed in all Detected in all tissues 8,385 8,459
Mixed Detected in at least two tissues, but not in all, and not part of any of the categories above 2,484 2,537
Not detected Not present in any of the analyzed tissues (under cutoff) 1,021 1,015
Total Total number of genes analyzed 18,684 18,684
Total elevated Total number of tissue-enriched, group-enriched, and tissue-enhanced genes 6,794 6,673
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Genes identified as “expressed in all tissues” are expected to
be either “housekeeping” genes for which the protein product is
needed in every cell, such as proteins involved in transcription,
translation, and energy metabolism, or genes expressed in cell
types that are present in all tissue types, such as lymphocytes,
macrophages, fibroblasts, and endothelial cells. HPA and GTEx
data largely overlap for this category as well, with 7,563 genes
identified as “expressed in all” by both resources (Fig 3B).
Between 800 and 900 genes were only identified in one of the
two datasets, and a more detailed analysis shows that the vast
majority of these genes were identified as “mixed” by the other
dataset (Fig 3B). This suggests that these genes move between
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Figure 2. Classification of all protein-coding genes using transcriptomics data.
(A) Pie chart showing the number of genes that fall into each expression specificity category, based on the classifications of HPA (32 tissues, 137 samples) (with a cutoff of 0.5
FPKM). (B) The number of protein-coding genes classified as tissue enriched (dark blue), group enriched (medium blue), and tissue enhanced (light blue) based on the
HPA dataset. (C) Pie chart showing the number of genes that fall into each expression specificity category, based on the classifications of GTEx (30 tissues, 2,510 samples) (Keen
& Moore, 2015) (with a cutoff of 0.5 FPKM). (D) The number of protein-coding genes classified as above based on GTEx dataset. (E). Barplot showing the overlap of
tissue-enriched genes between the two datasets. All genes that are tissue enriched in either dataset are depicted. Genes classified as tissue enriched/group enriched/tissue
enhanced in the same tissue in both datasets are shown in blue; genes only enriched in one of the datasets are shown in yellow (only HPA) or orange (only GTEx).
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categories based on the relatively arbitrary FPKM cutoff and
indicates that expression in a single tissue below the detection
threshold makes a gene move from “expressed in all” to
“mixed”.
The variation in protein profiles between individuals
A relevant question arising is the level of interindividual variation
in gene expression levels. A comparison of individual variation for
“housekeeping” genes (defined as expressed in all analyzed tissues)
and genes with a more tissue-restricted expression using GTEx data
is presented in Fig 3C for three different tissues (lung, brain, and
skin) that are represented by a large number of biological replicates.
For all three tissues, the coefficient of variation (CV) in the
“expressed in all” category shifted toward the lower side, suggesting
that genes expressed in all tissues seem to vary less between indi-
viduals for a particular tissue as compared to genes with a tissue-
restricted expression pattern. This illustrates that the proteins found
in all tissues are expressed at relatively similar levels across the
analyzed tissues, suggesting, as perhaps expected, that these
proteins that are involved in “basic functions” are required at
similar concentrations in the various tissue types.
Building genome-scale metabolic models for
human tissues
High-quality genome-wide proteomics and transcriptomics data can
be used for generating and improving context-specific biological
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Figure 3. Protein classification and interindividual variations.
(A) Venn diagrams showing the overlap between tissue-elevated genes between the two datasets, HPA in light green and GTEx in light blue. (B) Venn diagram showing
the overlap between genes classified as “expressed in all tissues” between the two datasets. The pie charts show the classification of the non-overlapping genes in the dataset
where the gene was not detected in all tissues. (C) Comparison of interindividual variation between genes that are annotated as “expressed in all tissues” and all other
genes, in lung, brain, and skin (these tissues were selected because they have a large number of biological replicates). The plots illustrate the distribution of the coefficient of
variation (CV) within the tissue for all genes in each of the two classes (red: expressed in all, black: other). The CV is shifted toward the lower side in the “expressed in all”
category (P  0.001), suggesting that genes that are expressed in all tissues have lower variation between individuals.
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networks including protein–protein interaction (PPI), regulatory,
signaling, and metabolic networks (Papin et al, 2005; Qian et al,
2005; Bossi & Lehner, 2009) in order to gain further insights into
the differences in cellular functions across tissues. Genome-scale
metabolic models (GEMs) that can be reconstructed directly from
proteomics or transcriptomics data are particularly well suited for
the analysis of biological functions, since they can be applied to
examine the metabolic functions associated with a given cell type.
Several studies have recently reported the use of proteomics data
to reconstruct GEMs for analyzing metabolic processes across dif-
ferent cell and tissue types in humans (Mardinoglu & Nielsen,
2015; O’Brien et al, 2015; Yizhak et al, 2015; Bjornson et al, 2016)
and mice (Mardinoglu et al, 2015b). GEMs contain thousands of
biochemical reactions and their catalyzing protein-coding genes in
a cell/tissue, which generate a complex network of molecular
interactions capturing the metabolic functions of this cell/tissue
(Fig 4A). This reaction network is converted into a computational
model using a stoichiometric (S) matrix and can be applied for the
analysis of physiological data collected from both healthy and
diseased states (Mardinoglu & Nielsen, 2012; Mardinoglu et al,
2013b).
The first human GEMs, Recon1 (Duarte et al, 2007) and EHMN
(Ma et al, 2007), were developed nearly 10 years ago and have
now grown to the level where they can be used for predicting the
metabolic response of cell/tissue to a given perturbation. These
integrative models allowed the identification of new drug target
candidates by theoretical analyses (Frezza et al, 2011), and many
enzymes have already been proposed as drug targets for cancer
treatment (Yizhak et al, 2015). Recently, more comprehensive
generic human GEMs including Recon2 (Thiele et al, 2013) and
HMR2 (Mardinoglu et al, 2014a) were constructed by integrating
the components of the first generic human GEMs with manually
reconstructed context-specific GEMs. Recon2 covers the content of
the HepatoNet, a manually reconstructed GEM for hepatocytes
(Gille et al, 2010), whereas HMR2 covers the content of both
HepatoNet and iAdipocytes1809, a manually reconstructed GEM
for adipocytes (Mardinoglu et al, 2013a). HMR2 also includes the
extensive description of lipid metabolism present in human adipo-
cytes and hepatocytes. The number of reactions, metabolites, and
genes incorporated in each model as well as the conceptual evolu-
tion of global reconstructions of human metabolism is presented
in Fig 4B. As illustrated in Fig 4B, HMR2 is the most comprehen-
sive global reconstruction of human metabolism and this model
together with other generic models of human metabolism has
served as a basis for the reconstruction of context-specific GEMs
(Fig 4C).
Context-specific GEMs were generated by manually curating the
existing literature as well as by using various algorithms that have
been reviewed elsewhere (Machado & Herrgard, 2014). For
instance, the recently developed tINIT algorithm enables the recon-
struction of simulation-ready GEMs based on proteomics data and
metabolic functions that are known to occur in the cell/tissue of
interest (Agren et al, 2014). The implementation of a metabolic
function related to bile acid synthesis into the liver-specific GEM is
shown as an example in Fig 4D. Recently, 32 tissue-specific GEMs
for healthy human tissues were generated by integrating RNA-seq
data from the HPA in combination with the tINIT algorithm and
they were used to compare the metabolic differences between these
tissues (Uhlen et al, 2015). GEMs reconstructed based on RNA-seq
data successfully predicted tissue-specific functions. For instance,
the liver GEM was the only model that could successfully perform
metabolic functions related to bile acid synthesis. Moreover, the
liver GEM was able to perform all defined human metabolic func-
tions and it was the largest GEM in terms of incorporated reactions,
metabolites, and genes, reflecting its high metabolic activity
compared to the other analyzed tissues. A list of the various cell-/
tissue-specific GEMs that have been generated so far, either in
physiological or in disease states, is presented in Table 3.
Applying context-dependent GEMs for analyzing
human diseases
Context-specific GEMs in combination with omics data obtained in
disease-specific contexts have been used to elucidate the metabolic
capabilities of cells/tissues involved in metabolism-related disorders
including obesity (Mardinoglu et al, 2013a, 2014b, 2015a), non-
alcoholic fatty liver disease (NAFLD) (Mardinoglu et al, 2014a;
Hyo¨tyla¨inen et al, 2016), type 2 diabetes (T2D) (Varemo et al,
2015), and aging (Yizhak et al, 2013), as well as to determine
unique metabolic properties of cancer cells (Agren et al, 2012; Gatto
et al, 2014; Nam et al, 2014) and even individual cell lines (Yizhak
et al, 2014a,b; Gatto et al, 2015; Ghaffari et al, 2015) and tumors
(Agren et al, 2014). Each of these studies advanced our understand-
ing of the molecular mechanisms underlying these diseases and
allowed the discovery of drug targets or biomarkers that can be used
for designing effective treatment strategies.
Recently, a GEM for skeletal myocytes was reconstructed using
cell type-specific RNA-seq data and incorporating cell type-specific
proteomics data from the HPA. First, the presence/absence of each
enzyme in myocytes was determined and based on this information
the corresponding metabolic reaction was incorporated into the
myocyte-specific GEM (Varemo et al, 2015). The model was
employed for characterizing the metabolic alterations in skeletal
muscle in response to T2D based on the meta-analysis of six
published datasets on T2D muscle gene expression. The metabolic
alterations observed in the skeletal muscle T2D patients involved
differences in pyruvate oxidation, tetrahydrofolate metabolism, and
branched-chain amino acid catabolism.
The interplay between a large number of biological pathways
and the significant variation between patients makes it extremely
difficult to identify effective drug targets and biomarkers for meta-
bolic diseases. Personalized GEMs that account for interindividual
differences as well as for the unique characteristics of disease
progression in each individual (Agren et al, 2014) present a poten-
tial solution to these issues. In a recent study, personalized cancer
GEMs for six hepatocellular carcinoma (HCC) patients as well as
83 healthy cell-specific GEMs were reconstructed using the tINIT
algorithm to integrate proteomics data from the HPA and meta-
bolic functions that are present in human cells (Agren et al,
2014). Based on these personalized GEMs, anticancer drug targets
that can be used for inhibiting the HCC tumor growth in each
patient were identified. One of the targets, predicted to be effec-
tive in all patients, was experimentally validated in human HCC
cancer cell lines. Overall, the observation that fat oxidation was
increased in the analyzed HCC tumors indicated that targeting this
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metabolic process could be used for developing treatment
strategies for HCC.
Another recent application of GEMs in the context of HCC is
presented in the study of Bjo¨rnson et al (2015). In this case, gene
expression data from approximately 360 HCC tumors and 50 non-
cancerous liver samples were analyzed using a HCC-specific GEM.
Interestingly, a group of patients showed an increased fat oxida-
tion, whereas another group showed a decreased fat oxidation.
The fact that HCC tumors from different patients may have
completely opposite metabolic programming highlights that careful
stratification of HCC patients and personalized medicine
approaches are highly advantageous for developing effective treat-
ment strategies. Overall, these studies provide valuable insights
into inter- and intratumor heterogeneity and point out that it
might be extremely difficult to treat all different HCC patients with
a single drug. This drug can be effective in the right context, that
is, in a given patient or patient group. Therefore, personalized
GEMs and their predictions of a patient’s response to different
drugs can be extremely useful for guiding precision medicine
approaches.
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Figure 4. Genome-scale metabolic models for human cells/tissues.
(A) GEMs incorporate the known biochemical reactions and their catalyzing enzymes in a particular cell/tissue type. The information related to the reaction–gene association
is used for the reconstruction of context-specific GEMs. (B) The continuously increasing number of reactions, metabolites, and genes included in generic human GEMs and
manually curated cell-/tissue-specific GEMs generated in the recent years is shown. (C) High-throughput omics data including proteomics, transcriptomics, and
metabolomics have been used for reconstructing cell-/tissue-specific GEMs based on generic human GEMs. (D) The metabolic tasks that are known to occur in a given human
cell/tissue need to be defined to generate functional cell-/tissue-specific GEMs. The definition of the metabolic task related to bile acid synthesis in the liver is
presented. Glucose, cysteine, phenylalanine, oxygen (O2), and phosphate (Pi) must be taken up, whereas urea, water (H2O), and carbon dioxide (CO2) must be secreted in order
to successfully simulate bile acid synthesis in liver GEM.
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Concluding remarks
Here, we reviewed some of the publicly available human transcrip-
tomics data resources with a focus on the expression data for
protein-coding genes. Tissue-restricted and tissue-enriched genes
can be consistently defined in a genome-wide manner by two inde-
pendent datasets generated using either fresh surgically removed
tissues or postmortem tissues taken within 24 hours after the death
of the individual. Thus, comprehensive lists of protein-coding genes
can be compiled for all the major tissues of the human body (see
Table EV1), with their quantitative expression profiles generated by
deep sequencing of the transcriptome.
The use of high-quality proteomics and transcriptomics data in
combination with metabolic modeling allows for functional analyses
in the context of different pathologies, for example, by comparing
GEMs reconstructed using data from healthy and diseased subjects.
On the one hand, a comparison of the healthy vs. diseased GEM
topology can provide insights into how cancer metabolism differs
from metabolism of the healthy tissue (Gatto et al, 2014; Bjo¨rnson
et al, 2015; Zhang et al, 2015). Furthermore, GEMs can be used for
identifying drug targets (Agren et al, 2014), and therefore, their inte-
gration with omics data generated in a clinical setup can be applied
to guide precision medicine in different disease types. Further
improvement and expansion of GEMs to cover other biological
processes, for example, protein secretion pathways and protein
synthesis (Feizi et al, 2013), will allow this modeling framework to
capture dysfunction of key cellular pathways in a range of different
pathologies, potentially leading to the identification of new
treatment strategies and biomarkers.
The transcriptomics data can be complemented with immunohis-
tochemistry to define protein localization in the subcompartments
of each tissue and organ down to the single-cell level (www.pro-
teinatlas.org). Moreover, extending these tissue profiles to include
splice variants and protein modifications is important for improving
Table 3. List of generic and cell-/tissue-specific human GEMs.
Model name Application References
Generic human GEMs
Recon1 Integration of genomic and bibliomic data (Duarte et al, 2007)
EHMN Integration of genomic and bibliomic data (Ma et al, 2007)
HMR Integration of previous generic human GEMs and publicly available databases (Agren et al, 2012)
Recon2 Community-based reconstruction of human metabolism (Thiele et al, 2013)
HMR2 Incorporation of extensive lipid metabolism into the generic human GEM (Mardinoglu et al, 2014a)
Cell-/tissue-specific GEMs
Red blood cell Analysis of the metabolic loads in red blood cells (Wiback & Palsson, 2002)
Mitochondria Study of the human mitochondrial metabolism (Vo et al, 2004)
Fibroblasts Metabolic alterations in Leigh syndrome (Vo et al, 2007)
HepatoNet1 Investigation of hepatic enzyme deficiencies (Gille et al, 2010)
Computational liver model Discovery of biomarkers of liver disorders including hyperammonemia
and hyperglutaminemia
(Jerby et al, 2010)
Kidney Prediction of causal drug off-targets that impact kidney function (Chang et al, 2010)
Brain (three neuron
types and astrocytes)
Revealing the metabolic alterations in Alzheimer’s disease (Lewis et al, 2010)
IAB-AMQ-1410 Analysis of the host–pathogen interactions with Mycobacterium tuberculosis (Bordbar et al, 2010)
Multitissue (hepatocytes,
myocytes, and adipocytes)
Revealing the metabolic alterations in T2D (Bordbar et al, 2011a)
Erythrocyte (iAB-RBC-283) Revealing the complexity in the functional capabilities of
human erythrocyte metabolism
(Bordbar et al, 2011b)
69 cell-specific GEMs Studying the metabolic differences between healthy cells and cancers (Agren et al, 2012)
126 tissue-specific GEMs Comparative analysis between healthy tissues and tumor (Wang et al, 2012)
CardioNet The effect of oxygen and substrate supply on the efficiency of
selected metabolic functions of cardiomyocytes
(Karlstaedt et al, 2012)
iAdipocytes1809 Revealing the metabolic differences in obese subjects (Mardinoglu et al, 2013a)
Tissue-specific GEMs Studying the metabolic differences between healthy tissues and cancers (Nam et al, 2014)
Liver GEM Studying urea metabolism in liver tissue (Vlassis et al, 2014)
83 cell-specific GEMs Defining the major metabolic functions in human cell types (Agren et al, 2014)
iHepatocytes2322 Revealing the metabolic alterations in response to NAFLD (Mardinoglu et al, 2014a)
iMyocyte2419 Revealing the metabolic alterations in response to T2D (Varemo et al, 2015)
32 tissue-specific GEMs Global analysis of the metabolic functions in major human tissues (Uhlen et al, 2015)
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our understanding of the role of the isoform proteome and post-
translational modifications in human physiology and disease.
Finally, spatial proteomics using fluorescent-based antibody profil-
ing (Marx, 2015) can provide even higher resolution with precise
localizations of the corresponding proteins down to subcellular
compartments and various substructures. The integration of
transcriptomics data with other large-scale data, such as mass
spectrometry-based proteomics, antibody-based profiling, and
metabolomics, can thus generate an important molecular knowledge
base for systems biology of human health and disease.
Expanded View for this article is available online.
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